Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE 3 STUDY OF EFFICACY OF TRANEXAMIC ACID IN BRAIN TUMORS RESECTIONS

NCT01655927 is registered in ClinicalTrials.gov with Colombian Foundation for Epilepsy and Neurological Disease as lead sponsor.

NCT NCT01655927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01655927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE 3 STUDY OF EFFICACY OF TRANEXAMIC ACID IN BRAIN TUMORS RESECTIONS
Lead sponsor
Colombian Foundation for Epilepsy and Neurological Disease
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2012
Completion date
Not reported
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytomas, brain tumors, gliomas, meningiomas, neoplasms